- Home
- CING vs PIII Comparison
CING vs PIII Comparison
Compare CING & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CING
- PIII
- Stock Information
- Founded
- CING 2012
- PIII 2015
- Country
- CING United States
- PIII United States
- Employees
- CING N/A
- PIII N/A
- Industry
- CING Biotechnology: Pharmaceutical Preparations
- PIII Medical/Nursing Services
- Sector
- CING Health Care
- PIII Health Care
- Exchange
- CING Nasdaq
- PIII Nasdaq
- Market Cap
- CING 26.7M
- PIII 28.6M
- IPO Year
- CING 2021
- PIII N/A
- Fundamental
- Price
- CING $3.86
- PIII $8.75
- Analyst Decision
- CING Strong Buy
- PIII Strong Buy
- Analyst Count
- CING 4
- PIII 3
- Target Price
- CING $31.00
- PIII $17.50
- AVG Volume (30 Days)
- CING 153.1K
- PIII 7.1K
- Earning Date
- CING 11-06-2025
- PIII 08-14-2025
- Dividend Yield
- CING N/A
- PIII N/A
- EPS Growth
- CING N/A
- PIII N/A
- EPS
- CING N/A
- PIII N/A
- Revenue
- CING N/A
- PIII $1,461,823,000.00
- Revenue This Year
- CING N/A
- PIII N/A
- Revenue Next Year
- CING N/A
- PIII $9.46
- P/E Ratio
- CING N/A
- PIII N/A
- Revenue Growth
- CING N/A
- PIII 4.20
- 52 Week Low
- CING $3.02
- PIII $5.80
- 52 Week High
- CING $7.00
- PIII $29.19
- Technical
- Relative Strength Index (RSI)
- CING 43.49
- PIII 71.27
- Support Level
- CING $3.61
- PIII $8.08
- Resistance Level
- CING $4.12
- PIII $8.93
- Average True Range (ATR)
- CING 0.25
- PIII 0.41
- MACD
- CING 0.00
- PIII 0.11
- Stochastic Oscillator
- CING 30.91
- PIII 91.73
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.